These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20799475)

  • 21. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G
    Expert Opin Biol Ther; 2003 Apr; 3(2):371-6. PubMed ID: 12662149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacological basis of anti-IgE therapy.
    Chang TW
    Nat Biotechnol; 2000 Feb; 18(2):157-62. PubMed ID: 10657120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-IgE therapy in persistent allergic asthma].
    Skiepko R; Zietkowski Z; Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A
    Przegl Lek; 2009; 66(3):141-4. PubMed ID: 19689039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
    Casale TB;
    Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary leukotriene E4 levels in children with allergic rhinitis treated with specific immunotherapy and anti-IgE (Omalizumab).
    Kopp MV; Mayatepek E; Engels E; Brauburger J; Riedinger F; Ihorst G; Wahn U; Kuehr J
    Pediatr Allergy Immunol; 2003 Oct; 14(5):401-4. PubMed ID: 14641611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M; Jenerowicz D; Silny W
    Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
    Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
    Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-IgE antibody therapy.
    MacGlashan D
    Clin Allergy Immunol; 2002; 16():519-32. PubMed ID: 11577557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Specific immunotherapy and therapeutic strategies in allergic diseases. What's new?].
    Tonnel AB
    Bull Acad Natl Med; 2005 Oct; 189(7):1475-87; discussion 1488-9. PubMed ID: 16669146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injection of anti-IgE antibodies will suppress IgE and allergic symptoms.
    Patalano F
    Allergy; 1999 Feb; 54(2):103-10. PubMed ID: 10221432
    [No Abstract]   [Full Text] [Related]  

  • 36. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
    D'Amato G; Oldani V; Donner CF
    Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.
    Berger WE
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):152-60; quiz 161-2, 208. PubMed ID: 11868919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.